# Thermo Fisher Scientific vs UnitedHealth Group

URL: https://funkfolio.com/compare/tmo-vs-unh

> Thermo Fisher Scientific ($254.5B, P/E 36.2) and UnitedHealth Group ($349.2B, P/E 22.2) compared: size, valuation, margins, debt, cash and price change.

---

## Thermo Fisher Scientific vs UnitedHealth Group

Thermo Fisher Scientific (TMO), health care, and UnitedHealth Group (UNH), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

UnitedHealth Group is worth $349.2B on the stock market and Thermo Fisher Scientific $254.5B: UnitedHealth Group is valued at 37% more. Thermo Fisher Scientific trades at 36.2 times earnings and UnitedHealth Group at 22.2; operating margins in their latest fiscal years were 17.4% and 4.24%. Over the past year Thermo Fisher Scientific's share price has moved +20.0% and UnitedHealth Group's +31.4%.

### Key facts

- **Thermo Fisher Scientific market value:** $254.5B
- **UnitedHealth Group market value:** $349.2B
- **Thermo Fisher Scientific P/E:** 36.2
- **UnitedHealth Group P/E:** 22.2
- **Thermo Fisher Scientific revenue:** $44.6B FY to 2025-12-31
- **UnitedHealth Group revenue:** $447.6B FY to 2025-12-31
- **Superinvestors holding both:** 9

Market values as of 18 Nov 2026, 06:57 UTC.

Thermo Fisher Scientific vs UnitedHealth Group: every measure side by side

| Measure | Thermo Fisher Scientific | UnitedHealth Group |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United States |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $254.5B lower | $349.2B higher |
| Revenue | $44.6B lower | $447.6B higher |
| Earnings | $6.7B lower | $12.1B higher |
| Employees | 125,000 lower | 390,000 higher |
| Total assets | $110.3B lower | $309.6B higher |
| Valuation |  |  |
| P/E | 36.2 higher | 22.2 lower |
| P/S | 5.7 higher | 0.8 lower |
| P/B | 4.6 higher | 3.6 lower |
| Dividend yield | 0.27% lower | 2.20% higher |
| Profitability |  |  |
| Operating margin | 17.4% higher | 4.24% lower |
| Balance sheet |  |  |
| Net assets | $53.4B lower | $100.1B higher |
| Total liabilities | $56.8B lower | $207.9B higher |
| Total debt | $39.4B lower | $77.7B higher |
| Cash on hand | $9.9B lower | $24.4B higher |
| Price change |  |  |
| Today | -0.66% higher | -5.42% lower |
| 1 year | +20.0% lower | +31.4% higher |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Thermo Fisher Scientific 121.1, UnitedHealth Group 121.6.

- Thermo Fisher Scientific (TMO)
- UnitedHealth Group (UNH)

Thermo Fisher Scientific and UnitedHealth Group share prices over one year, rebased to 100: Thermo Fisher Scientific ends at 121.1, UnitedHealth Group at 121.6.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | TMO | UNH |
| --- | --- | --- |
| Nov 28, 2025 | 104.2 | 102.9 |
| Dec 31, 2025 | 102.2 | 103.0 |
| Jan 30, 2026 | 102.0 | 89.5 |
| Feb 27, 2026 | 91.9 | 91.5 |
| Mar 31, 2026 | 86.7 | 84.4 |
| Apr 30, 2026 | 84.4 | 115.6 |
| May 29, 2026 | 86.8 | 118.7 |
| Jun 30, 2026 | 88.4 | 129.7 |
| Jul 31, 2026 | 101.3 | 129.3 |
| Aug 31, 2026 | 108.8 | 121.5 |
| Sep 30, 2026 | 119.0 | 114.5 |
| Oct 30, 2026 | 122.9 | 127.0 |
| Nov 17, 2026 | 121.1 | 121.6 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (9)

- [Jeremy Grantham (co-founder)](https://funkfolio.com/gurus/jeremy-grantham) 4.3% / 2.2%
- [Temasek](https://funkfolio.com/gurus/temasek) 2.2% / 0.5%
- [Doug Silverman](https://funkfolio.com/gurus/doug-silverman) 2.0% / 1.4%
- [Andrew Spokes](https://funkfolio.com/gurus/farallon) 1.6% / 2.0%
- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) 1.1% / 1.6%
- [Ken Fisher](https://funkfolio.com/gurus/ken-fisher) 0.6% / 1.1%
- [Steve Cohen](https://funkfolio.com/gurus/steve-cohen) 0.2% / 0.5%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.2% / 0.3%
- [Paul Tudor Jones](https://funkfolio.com/gurus/paul-tudor-jones) 0.1% / 0.5%

#### Thermo Fisher Scientific only (15)

- [Nick Train](https://funkfolio.com/gurus/nick-train) 12.4%
- [Larry Robbins](https://funkfolio.com/gurus/larry-robbins) 6.3%
- [Wallace Weitz](https://funkfolio.com/gurus/wallace-weitz) 4.9%
- [Andreas Halvorsen](https://funkfolio.com/gurus/andreas-halvorsen) 2.8%
- [Harry Burn](https://funkfolio.com/gurus/harry-burn) 2.7%
- [Steven Romick](https://funkfolio.com/gurus/steven-romick) 2.0%
- [Diamond Hill team](https://funkfolio.com/gurus/diamond-hill) 1.6%
- [John Armitage](https://funkfolio.com/gurus/john-armitage) 1.4%
- [Primecap team](https://funkfolio.com/gurus/primecap) 0.8%
- [Daniel Sundheim](https://funkfolio.com/gurus/daniel-sundheim) 0.7%
- [Tom Gayner](https://funkfolio.com/gurus/tom-gayner) 0.4%
- [Baillie Gifford team](https://funkfolio.com/gurus/baillie-gifford) 0.4%
- [Stanley Druckenmiller](https://funkfolio.com/gurus/stanley-druckenmiller) 0.2%
- [David Shaw (founder)](https://funkfolio.com/gurus/david-shaw) 0.2%
- [Joel Greenblatt](https://funkfolio.com/gurus/joel-greenblatt) 0.2%

#### UnitedHealth Group only (20)

- [Samantha McLemore](https://funkfolio.com/gurus/samantha-mclemore) 5.2%
- [Sequoia Fund team](https://funkfolio.com/gurus/sequoia-fund) 4.2%
- [Bill Smead](https://funkfolio.com/gurus/bill-smead) 2.5%
- [Christopher Davis](https://funkfolio.com/gurus/christopher-davis) 2.0%
- [Lew Sanders](https://funkfolio.com/gurus/lew-sanders) 2.0%
- [Mairs & Power team](https://funkfolio.com/gurus/mairs-and-power) 1.7%
- [Pat English](https://funkfolio.com/gurus/pat-english) 1.4%
- [Jim Simons (1938–2024)](https://funkfolio.com/gurus/jim-simons) 1.1%
- [Charles Brandes (founder)](https://funkfolio.com/gurus/charles-brandes) 1.0%
- [Duan Yongping](https://funkfolio.com/gurus/duan-yongping) 0.9%
- [Rajiv Jain](https://funkfolio.com/gurus/rajiv-jain) 0.8%
- [Stephen Yacktman](https://funkfolio.com/gurus/stephen-yacktman) 0.8%
- [Chase Coleman](https://funkfolio.com/gurus/chase-coleman) 0.5%
- [C.T. Fitzpatrick](https://funkfolio.com/gurus/ct-fitzpatrick) 0.5%
- [Israel Englander](https://funkfolio.com/gurus/israel-englander) 0.5%
- [Robert Pitts](https://funkfolio.com/gurus/robert-pitts) 0.4%
- [Sarah Ketterer](https://funkfolio.com/gurus/sarah-ketterer) 0.3%
- [Cliff Asness](https://funkfolio.com/gurus/cliff-asness) 0.3%
- [Tweedy, Browne team](https://funkfolio.com/gurus/tweedy-browne) 0.1%
- [Jensen team](https://funkfolio.com/gurus/jensen-investment) &lt;0.1%

Percentages are each holding's share of that investor's reported portfolio (under "Both": Thermo Fisher Scientific / UnitedHealth Group). [Who owns TMO](https://funkfolio.com/stock/TMO/superinvestors) · [Who owns UNH](https://funkfolio.com/stock/UNH/superinvestors)

### More on Thermo Fisher Scientific

- [Thermo Fisher Scientific (TMO) stock page](https://funkfolio.com/stock/TMO)
- [Thermo Fisher Scientific market cap](https://funkfolio.com/stock/TMO/market-cap)
- [Thermo Fisher Scientific revenue](https://funkfolio.com/stock/TMO/revenue)
- [Thermo Fisher Scientific P/E ratio](https://funkfolio.com/stock/TMO/pe-ratio)
- [Thermo Fisher Scientific operating margin](https://funkfolio.com/stock/TMO/operating-margin)
- [Thermo Fisher Scientific total debt](https://funkfolio.com/stock/TMO/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on UnitedHealth Group

- [UnitedHealth Group (UNH) stock page](https://funkfolio.com/stock/UNH)
- [UnitedHealth Group market cap](https://funkfolio.com/stock/UNH/market-cap)
- [UnitedHealth Group revenue](https://funkfolio.com/stock/UNH/revenue)
- [UnitedHealth Group P/E ratio](https://funkfolio.com/stock/UNH/pe-ratio)
- [UnitedHealth Group operating margin](https://funkfolio.com/stock/UNH/operating-margin)
- [UnitedHealth Group total debt](https://funkfolio.com/stock/UNH/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Thermo Fisher Scientific against its closest peers

- [Thermo Fisher Scientific vs Amgen](https://funkfolio.com/compare/amgn-vs-tmo)
- [Thermo Fisher Scientific vs AstraZeneca](https://funkfolio.com/compare/azn-vs-tmo)
- [Thermo Fisher Scientific vs Novartis](https://funkfolio.com/compare/nvs-vs-tmo)
- [Thermo Fisher Scientific vs Gilead Sciences](https://funkfolio.com/compare/gild-vs-tmo)

#### UnitedHealth Group against its closest peers

- [UnitedHealth Group vs Merck & Co](https://funkfolio.com/compare/mrk-vs-unh)
- [UnitedHealth Group vs Novartis](https://funkfolio.com/compare/nvs-vs-unh)
- [UnitedHealth Group vs AbbVie](https://funkfolio.com/compare/abbv-vs-unh)
- [UnitedHealth Group vs AstraZeneca](https://funkfolio.com/compare/azn-vs-unh)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Thermo Fisher Scientific or UnitedHealth Group?**

By market value, UnitedHealth Group is the larger: $349.2B against $254.5B for Thermo Fisher Scientific. By revenue in its latest fiscal year, UnitedHealth Group is the larger: $447.6B against $44.6B for Thermo Fisher Scientific.

**Which has the higher P/E ratio?**

Thermo Fisher Scientific: 36.2, against 22.2 for UnitedHealth Group. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.

**Which has the higher operating margin?**

Thermo Fisher Scientific: 17.4%, against 4.24% for UnitedHealth Group. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has the higher dividend yield?**

UnitedHealth Group: 2.20%, against 0.27% for Thermo Fisher Scientific. Dividend yield is the last twelve months' dividends as a share of today's share price.

**Which has more debt?**

UnitedHealth Group: $77.7B, against $39.4B for Thermo Fisher Scientific. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Thermo Fisher Scientific and UnitedHealth Group?**

In their latest 13F filings, Jeremy Grantham (co-founder), Temasek, Doug Silverman, Andrew Spokes, Dodge & Cox team, Ken Fisher, Steve Cohen, Ken Griffin and Paul Tudor Jones hold both.

### Cite this page

Funkfolio, “Thermo Fisher Scientific vs UnitedHealth Group”, data as of 18 November 2026. https://funkfolio.com/compare/tmo-vs-unh

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
